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Abstract: The Organization for Economic Cooperation and Development (OECD) tracks 
and reports annually on more than 1,200 health system measures across 30 industrialized 
countries, ranging from population health status and nonmedical determinants of health to 
health care resources and utilization. Based on analysis of OECD health data from 2008, the 
United States continues to differ markedly from other countries on a number of health system 
measures. The U.S. has a comparatively low number of hospital beds and physicians per cap-
ita, and patients in the U.S. have fewer hospital and physician visits than most other countries. 
At the same time, spending per hospital visit is highest in the U.S., and American patients 
are among the most likely to receive procedures requiring complex technology. The nation 
now ranks in the bottom quartile in life expectancy among OECD countries and has seen the 
smallest improvement in this metric over the past 20 years.
            
OVERVIEW
Findings from cross-national comparisons of health care systems can inform pub-
lic policy, highlight areas where nations could improve, and yield benchmarks for 
high performance. The Organization for Economic Cooperation and Development 
(OECD) tracks and reports annually on more than 1,200 health system measures 
across 30 industrialized countries, ranging from population health status and non-
medical determinants of health to health care resources and utilization. Since 1998, 
The Commonwealth Fund has sponsored an analysis of cross-national health systems 
based on OECD health data to place the performance of the U.S. health system in 
an international context and derive lessons for the nation’s health care leaders and 
policymakers.
Based on analysis of OECD health data from 2008, the United States con-
tinues to differ markedly from other countries on a number of health system mea-
sures.1 Health care spending in the U.S. in 2006 was significantly higher than in 
other industrialized countries, both per capita and as a percentage of gross domestic 
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product (GDP). The U.S. has a comparatively low 
number of hospital beds and physicians per capita, and 
patients in the U.S. have fewer hospital and physician 
visits than most other countries. At the same time, spend-
ing per hospital visit is highest in the U.S., and American 
patients are among the most likely to receive procedures 
requiring complex technology. The nation now ranks in 
the bottom quartile in life expectancy among OECD 
countries and has seen the smallest improvement in this 
metric over the past 20 years. According to one recent 
analysis, the U.S. had the highest rate of mortality 
amenable to health care among 19 OECD countries in 
2002–03.2
KEY FINDINGS
The comparative findings that follow are for 2006, 
although OECD data for 2004 and 2005 were used in a 
few instances, as is indicated in the exhibits. When data 
from those years were not available, no data are presented. 
All currency amounts are listed in U.S. dollars (USD) and 
adjusted for national differences in cost of living.
The U.S. Has the Highest Level of Health 
Care Spending
Health care spending per capita in the U.S. in •	
2006 ($6,714) was more than twice the median 
per capita expenditure of the 30 OECD industri-
alized countries ($2,880), and 50 percent greater 
than Norway ($4,520), the second-highest spend-
ing country (Exhibits 1 and 2).
Health care expenditures constituted 15.3 percent •	
of GDP in the U.S., while in other OECD coun-
tries it was generally less than 10 percent and did 
not exceed 11.3 percent.
Public health care spending per capita in the U.S. •	
($3,074) exceeded total health care spending per 
capita in half of the other OECD countries, and 
yet public programs in the U.S. covered only 27 
percent of the population.3
Per capita spending in the U.S. on outpatient care •	
($3,011) was almost four times higher than the 
OECD median ($759) and almost three times 
higher than any other OECD country.
Per capita spending in the U.S. on pharmaceu-•	
ticals ($843) was higher than any other OECD 
country, although pharmaceutical spending 
accounted for a lower share of total health expen-
ditures in the U.S. (12.6%) than the OECD 
median (16.6%).
The U.S. Has Relatively Few Physicians 
and Physician Visits
On a per capita basis, there were fewer practicing •	
physicians in the U.S.—2.4 per 1,000 popula-
tion—than most other OECD countries (Exhibit 
3). The median was 3.3 physicians.
The average number of physician visits per capita •	
in the U.S. (4.0) was lower than the OECD 
median (6.4) and lower than all but four of the 25 
countries that reported on this measure.
Hospital Stays in the U.S. Are Less 
Frequent and Shorter, but More Expensive
The number of hospital discharges per 1,000 •	
population in the U.S. (119) was in the bottom 
quartile among OECD countries and much lower 
than the OECD median of 162 (Exhibit 3).
The U.S. had among the fewest acute care hos-•	
pital beds per capita (2.7 per 1,000 population) 
among OECD countries (median was 3.4).
The average length of stay for acute care hospital-•	
izations in the U.S. (5.6 days) was one day shorter 
than the OECD median (6.6 days).
Spending per hospital discharge in the U.S. •	
($17,126) was 2.5 times higher than the OECD 
median ($6,867) and almost 50 percent higher 
than the Netherlands, the second-most-expensive 
OECD country ($11,522).
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Exhibit 1. Health Spending in Organization for Economic Cooperation  
and Development (OECD) Countries, 2006 
Total Health Spending
Public Health 
Care Spending 
per Capita
Outpatient 
Care Spending 
per Capita
Pharmaceutical Spending
 
Per Capita % of GDP Per Capita
% of Total 
Health 
Spending
Australia $2,999a 8.8%a $2,011a $947a $426a 14.2%a
Austria $3,606 10.1% $2,748 $895 $449 12.4%
Belgium $3,488 10.4% —c $637 $584 16.8%
Canada $3,678 10.0% $2,591 $920 $639 17.4%
Czech Republic $1,490 6.8% $1,309 $345 $349 23.4%
Denmark $3,349 9.5% —c $841 $286 8.5%
Finland $2,668 8.2% $2,027 $690 $389 14.6%
France $3,449 11.1% $2,750 $603 $564 16.4%
Germany $3,371 10.6% $2,591 $744 $500 14.8%
Greece $2,483 9.1% $1,529 —c $438 17.6%
Hungary $1,504 8.3% $1,066 $301 $466 31.0%
Iceland $3,340 9.1% $2,738 $826 $439 13.1%
Ireland $3,082 7.5% $2,413 —c —c —c
Italy $2,614 9.0% $2,018 $788 $524 20.0%
Japan $2,474a 8.2%a $2,046a $788a $489a 19.8%a
Korea $1,480 6.4% $815 $493 $381 25.8%
Luxembourg $4,303 7.3% $3,910 $1,018a $349a 8.4%a
Mexico $794 6.6% $351 $249 $182 22.9%
Netherlands $3,391 9.3% —c —c —c —c
New Zealand $2,448 9.3% $1,906 $599 $303 12.4%
Norway $4,520 8.7% $3,780 $830 $384 8.5%
Poland $910 6.2% $636 $170 $248 27.2%
Portugal $2,120 10.2% $1,495 $679 $451 21.3%
Slovak Republic $1,130a 7.1%a $840a $192a $360a 31.9%a
Spain $2,458 8.4% $1,751 $759 $533 21.7%
Sweden $3,202 9.2% $2,615 $1,084 $426 13.3%
Switzerland $4,311 11.3% $2,597 $1,166a $427a 10.5%a
Turkey $591a 5.7%a $422a n/a n/a n/a
United Kingdom $2,760 8.4% $2,408 —c —c —c
United States $6,714 15.3% $3,074 $3,011 $843 12.6%
OECD Median $2,880 8.9% $2,027 $759 $433 16.6%
Notes: All currency amounts are adjusted for differences in cost of living. 
a 2005 
b 2004 
c Data not available for 2006, 2005 or 2004 
Source: Organization for Economic Cooperation and Development, OECD Health Data, 2008 (Paris: OECD, June 2008).
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High-Tech Medical Procedures Are 
Performed at High Rates in the U.S.
Sophisticated imaging technology was compara-•	
tively prevalent in the U.S., with 33.9 computed 
tomography (CT) scanners and 26.5 magnetic 
resonance imaging (MRI) units per million popu-
lation, compared with 14.8 CT scanners and 7.7 
MRI units in the OECD median (Exhibit 4). 
Only two countries (Australia and Belgium) had 
more CT scanners per capita than the U.S., and 
only one country (Japan) had more MRI units.
For inpatient medical procedures involving •	
sophisticated technology, the U.S. was far above 
the OECD median for four procedures for which 
data are available. The U.S. had the highest rate 
among all countries for percutaneous coronary 
interventions (angioplasty and stenting), the 
second-highest rates of knee replacements and of 
patients undergoing dialysis treatment, and the 
fourth-highest rate of cardiac catheterizations 
(Exhibit 4).4
Several countries other than the U.S. showed com-•	
paratively high rates of imaging and procedures 
involving sophisticated technology. Germany in 
particular had high rates of cardiac catheteriza-
tion, percutaneous coronary interventions, and 
patients undergoing dialysis. Japan had the highest 
number of MRI units per million population and 
highest rate of patients undergoing dialysis.
Mortality
Life expectancy at birth in the U.S. was 77.8 •	
years, placing the nation in the bottom quartile 
among the 30 OECD countries in 2006 (Exhibit 
5). Ten countries had life expectancies at birth of 
over 80 years.
The U.S. had the smallest increase in life expec-•	
tancy among all OECD countries from 1986 to 
2006—3.1 years, compared with the median of 
4.7 years.
Exhibit 2. International Comparison of Spending on Health, 1980–2006
Average spending on health per capita ($US PPP) Total expenditures on health as percent of GDP
Source: Organization for Economic Cooperation and Development, OECD Health Data, 2008 (Paris: OECD, June 2008).
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Exhibit 3. Physicians and Hospitals in OECD Countries, 2006
Physicians Hospitals
Number of 
Practicing 
Physicians 
per 1,000 
Population
Average 
Number of 
Physician Visits 
per Capita
Hospital 
Discharges 
per 1,000 
Population
Number of 
Acute Care 
Hospital Beds 
per 1,000 
Population
Average 
Length of 
Stay for 
Acute Care
Hospital 
Spending per 
Discharge
Australia 2.8a 6.1 162a 3.5a 6.0a $6,993a
Austria 3.6 6.7 278a 6.1 5.8 —c
Belgium 4.0 7.5a 174a 4.3 7.7a $6,741a
Canada 2.1 5.9a 87a 2.8a 7.2a $11,093a
Czech Republic 3.6 12.9 204 5.4 7.8 $3,304
Denmark 3.6b 7.5b 171 3.1a 3.5a $8,369
Finland 2.7 4.3 196 3.1 4.8a $4,731
France 3.4 6.4 284 3.7 5.4 $4,333
Germany 3.5 7.0b 202 6.2 8.5 $4,852
Greece 5.0a —c 184b 3.9a 5.7b —c
Hungary 3.0 12.9 256a 5.5 6.1 $1,850a
Iceland 3.7 6.3 160 —c 5.5 —c
Ireland 2.9 —c 137 2.8a 6.6a —c
Italy 3.7 7.0a 141a 3.3 6.7a —c
Japan 2.1 13.7a 106a 8.2 19.2 $11,181a
Korea 1.7 11.8a 132a 6.8 n/a $3,278a
Luxembourg 2.8 6.0 172 4.6 7.4 $10,528a
Mexico 1.9 2.5b 55 1.0 3.9 $4,837
Netherlands 3.8 5.6 104a 3.0 6.6 $11,522a
New Zealand 2.3 —c 138b —c —c $4,935b
Norway 3.7 —c 177 3.0 5.0 $8,780a
Poland 2.2 6.6 184 4.7 6.1 $1,438
Portugal 3.4a 3.9a 104 3.0a 7.1a $7,109
Slovak Republic 3.1b 10.4 199 4.9 7.2 $1,539a
Spain 3.6 8.1 107 2.5a 6.7a $8,591
Sweden 3.5a 2.8 162 2.2 4.6 $8,631
Switzerland 3.8 —c 161 3.5 8.2 $8,888a
Turkey 1.6 3.1b 85b 2.5 n/a $2,842b
United Kingdom 2.5 5.1 125 2.2 7.5 —c
United States 2.4 4.0a 119a 2.7 5.6 $17,126a
OECD Median 3.3 6.4 162 3.4 6.6 $6,867
a 2005 
b 2004 
c Data not available for 2006, 2005 or 2004 
Source: Organization for Economic Cooperation and Development, OECD Health Data, 2008 (Paris: OECD, June 2008).
6 The Commonwealth Fund
Exhibit 4. Technologically Advanced Equipment and Procedures in OECD Countries, 2006 
Advanced Medical 
Technology 
(per Million Population)
Inpatient Medical Procedures  
Involving Sophisticated Technology  
(per 100,000 Population)
CT  
Scanners
MRI  
Units
Cardiac 
Catheterization
Percutaneous 
Coronary 
Intervention 
(PTCA or 
Stenting)
Knee 
Replacement
Patients 
Undergoing 
Dialysis
Australia 51.1a 4.9 333a 168a 144a 45
Austria 29.8 16.8 595a —c 187a 47
Belgium 39.8 7.1 518a 427a 152a 60a
Canada 12.0 6.2 196a 138a 130a 63
Czech Republic 13.1 3.8 —c 207a —c 57
Denmark 15.8 10.2b 32a 194a 106a 47a
Finland 14.8 15.2 30 152 188 29
France 10.0 5.3 —c —c 95b,d 59
Germany 16.7 7.7 979 353 121b,d 80
Greece 25.8a 13.2a —c —c —c 75b
Hungary 7.2 2.6 388a 326a 55a 54a
Iceland 26.3 19.7 316 200 100 17
Ireland 12.8 9.7 170 93 43 35
Italy 27.7a 15.0a 89a 345a 82a 71a
Japan —c 40.1a —c —c —c 207
Korea 33.7 13.6 —c —c 56 74b
Luxembourg 28.3 10.9 347 194 150 47
Mexico 3.6 1.4 8 2 3 43
Netherlands 8.2a 6.6a 202a —c 131a 32a
New Zealand 12.1b —c —c 102 90 48
Norway —c —c —c 247a —c —c
Poland 9.2 1.9 4 216 —c —c
Portugal 25.8 5.8 173 83 48 84a
Slovak Republic 12.1 4.5 —c —c —c 54
Spain 13.9 8.8 163 227 97 49
Sweden —c —c 11 173a 115 —c
Switzerland 18.7 14.0 134 113 158 —c
Turkey 7.8 3.5 —c —c —c 46a
United Kingdom 7.6 5.6 6 101 118 39
United States 33.9 26.5 434b 434b 176b 114a
OECD Median 14.8 7.7 173 194 115 51
a 2005 
b 2004 
c Data not available for 2006, 2005 or 2004 
d Source: McKinsey & Company, Accounting for the Cost of Health Care in the United States, 2007 
Source: Organization for Economic Cooperation and Development, OECD Health Data, 2008 (Paris: OECD, June 2008).
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According to an analysis of mortality and popula-•	
tion data from the World Health Organization, 
the U.S. had the highest rate of mortality ame-
nable to health care among 19 OECD countries 
in 2002–03.5 The U.S. had an age-standardized 
death rate of 109.7 per 100,000 population; 
France had the lowest rate, at 64.8.
DISCUSSION
Previous cross-national analyses of OECD data have 
examined a number of explanations for why the U.S. 
has higher health spending per capita. These include 
administrative complexity, the aging of the population, 
the practice of “defensive medicine” under threat of mal-
practice litigation, chronic disease burden, health care 
supply and utilization rates, access to care, and resource 
allocation.6
These studies have consistently shown that, 
despite higher spending, the U.S. has, on many mea-
sures, lower health care utilization rates than most other 
OECD countries. The 2006 OECD data reveal similar 
findings—for example, in the high costs and low fre-
quency associated with hospital discharges in the U.S. 
Some of these differences in average cost per discharge 
may be attributable to differences in patient case mix, 
the composition of the goods and services going into the 
treatment of a given medical condition, the prices paid 
by the hospitals for these goods and services, and the rela-
tive efficiency of hospitals. Furthermore, the administra-
tive complexity in the U.S. health care system requires 
that American hospitals employ far larger staffs to handle 
billing requirements. While these issues require further 
investigation, one important difference may be the avail-
ability and use of technology in hospitals and other 
settings. U.S. providers have more access to expensive, 
high-tech medical technology in the treatment of patients 
and seem to perform more medical procedures involv-
ing sophisticated technology than do providers in other 
OECD countries.
Likewise, outpatient expenditures in the U.S. 
are also substantially higher than those in other OECD 
countries. One factor that could explain this large dif-
ference is that in the U.S., many expensive procedures 
are performed in outpatient settings, in contrast to most 
OECD countries, where they are more likely to be inpa-
tient-based. For example, analysis of Medicare data shows 
that approximately half of beneficiaries receiving cardiac 
catheterization procedures, percutaneous transluminal 
coronary angioplasty, coronary bypass procedures, and 
knee replacements obtained them in outpatient settings.7 
This heavy reliance on outpatient settings for medical 
procedures has two potentially negative consequences. 
First, it may be more difficult to ensure quality in the 
use of these technologies in the less tightly regulated 
ambulatory setting. Second, there is evidence that when 
physicians have a direct or indirect financial interest in 
outpatient facilities, the volume of these procedures tends 
to rise significantly.8
CONCLUSION
Once again the United States has the highest level of 
spending among all OECD countries. While Americans 
have comparably few doctor visits and hospital days, their 
total expenditures are twice as high per capita as those 
of people in most other industrialized countries. One 
possible factor may be the proliferation of technologi-
cally advanced equipment and procedures. Yet despite 
this enormous investment, the U.S. has failed to achieve 
improvements in life expectancy comparable to its peers. 
This gap between the investment and what is delivered in 
return suggests health services in the U.S. are less effec-
tively deployed or come at a higher price.
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Exhibit 5. Mortality in OECD Countries, 2006 
Life Expectancy From Birtha 
(Years)
Mortality Amenable  
to Health Caref 
(Age-Standardized  
Death Rates per 100,000)
Females Males Total
Change  
1986–2006 1998–99 2002–03
Australia 83.5 78.7 81.1 5.0 88.0 71.3
Austria 82.7 77.1 79.9 5.6 108.9 84.5
Belgium 82.3 76.6 79.5 4.7 —g —g
Canada 82.7b 78.0b 80.4b 3.9d 88.9 76.8
Czech Republic 79.9 73.5 76.7 5.6
Denmark 80.7 76.1 78.4 3.6 113.0 100.8
Finland 83.1 75.9 79.5 4.7 116.2 93.3
France 84.4 77.3 80.9 5.3 75.6 64.8
Germany 82.4 77.2 79.8 5.2 106.2 90.1
Greece 82.0 77.1 79.6 3.2 97.3 84.3
Hungary 77.4 69.0 73.2 3.9
Iceland 83.0 79.4 81.2 3.3 —g —g
Ireland 82.1 77.3 79.7 6.1 134.4 103.4
Italy 83.8c 77.9c 80.9c 5.9e 88.8 74.0
Japan 85.8 79.0 82.4 4.3 81.4 71.2
Korea 82.4 75.7 79.1 9.8
Luxembourg 81.9 76.8 79.4 4.7 —g —g
Mexico 78.1 73.2 75.7 5.8
Netherlands 81.9 77.6 79.8 3.4 96.9 81.9
New Zealand 81.9 77.9 79.9 5.8 114.5 95.6
Norway 82.9 78.2 80.6 4.1 98.6 79.8
Poland 79.6 70.9 75.3 4.3
Portugal 82.3 75.5 78.9 5.5
Slovak Republic 78.2 70.4 74.3 3.2
Spain 84.4 77.7 81.1 4.4 84.3 73.8
Sweden 82.9 78.7 80.8 3.8 88.4 82.1
Switzerland 84.2 79.2 81.7 4.6 —g —g
Turkey 74.0 69.1 71.6 8.4
United Kingdom 81.1b 77.1b 79.1b 4.4d 130.0 102.8
United States 80.4b 75.2b 77.8b 3.1d 114.7 109.7
OECD Median 82.3 77.1 79.7 4.7 —g —g
a Source: Organization for Economic Cooperation and Development, OECD Health Data 2008, June 08 
b 2005 
c 2004 
d 1985-2005 
e 1984-2004 
f Countries’ age-standardized death rates before age 75; includes ischemic heart disease, diabetes, stroke, and bacterial infections.  
g Data not available 
Source: E. Nolte and C. M. McKee, “Measuring the Health of Nations: Updating an Earlier Analysis,” Health Affairs, Jan./Feb. 2008 27(1): 58–71.
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